Approval · Notice of Compliance 25971 · 2021
CLOZARIL: Notice of Compliance 25971
Issued June 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25971
- Date
- June 2, 2021
- Company
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update some language in the indications, dosage and administration and warnings and precautions sections of the PM and to migrate to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOZARIL | Not yet assigned | — |